Cargando…
Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300781/ http://dx.doi.org/10.1186/bcr1962 |
| _version_ | 1782226357433925632 |
|---|---|
| author | Murphy, ML Chan, SKW Gullick, WJ |
| author_facet | Murphy, ML Chan, SKW Gullick, WJ |
| author_sort | Murphy, ML |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3300781 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-33007812012-03-14 Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin? Murphy, ML Chan, SKW Gullick, WJ Breast Cancer Res Poster Presentation BioMed Central 2008 2008-05-13 /pmc/articles/PMC3300781/ http://dx.doi.org/10.1186/bcr1962 Text en Copyright ©2008 BioMed Central Ltd |
| spellingShingle | Poster Presentation Murphy, ML Chan, SKW Gullick, WJ Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin? |
| title | Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin? |
| title_full | Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin? |
| title_fullStr | Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin? |
| title_full_unstemmed | Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin? |
| title_short | Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin? |
| title_sort | why do most c-erbb-2/her-2-positive breast cancer patients fail to respond to herceptin? |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300781/ http://dx.doi.org/10.1186/bcr1962 |
| work_keys_str_mv | AT murphyml whydomostcerbb2her2positivebreastcancerpatientsfailtorespondtoherceptin AT chanskw whydomostcerbb2her2positivebreastcancerpatientsfailtorespondtoherceptin AT gullickwj whydomostcerbb2her2positivebreastcancerpatientsfailtorespondtoherceptin |